US testing capacity for COVID-19 boosted by Roche test and (belated) government actions: https://www.biocentury.com/article/304649 Roche’s stock is +5% in US trading (RHHBY) and +4% in Switzerland (ROG.SW), moves that equate to a (unduly) large increase in market cap.